FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056665 [Registered on: 21/08/2023] Trial Registered Prospectively
Last Modified On: 17/08/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective observational 
Study Design  Other 
Public Title of Study   A clinical study to evaluate the fluid response in patients undergoing neurosurgery. 
Scientific Title of Study   Tidal volume challenge to predict fluid responsiveness during neurosurgery in lateral position with low tidal volume ventilation, A prospective observational study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Niraj Kumar 
Designation  Professor 
Affiliation  ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) NEW DELHI 
Address  Room no 709 7th floor Dept of Neuroanesthesiology Critical Care Neuroscience center AIIMS Delhi 110029 New Delhi DELHI 110029 India

South
DELHI
110029
India 
Phone  09013770806  
Fax    
Email  drnirajaiims@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Niraj Kumar 
Designation  Professor 
Affiliation  ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) NEW DELHI 
Address  Room no 709 7th floor Dept of Neuroanesthesiology Critical Care Neuroscience center AIIMS Delhi 110029 New Delhi DELHI 110029 India

South
DELHI
110029
India 
Phone  09013770806  
Fax    
Email  drnirajaiims@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Niraj Kumar 
Designation  Professor 
Affiliation  ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS), NEW DELHI 
Address  Room no 709 7th floor Dept of Neuroanesthesiology Critical Care Neuroscience center AIIMS Delhi 110029 New Delhi DELHI 110029 India

South
DELHI
110029
India 
Phone  09013770806  
Fax    
Email  drnirajaiims@gmail.com  
 
Source of Monetary or Material Support  
ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS), New Delhi 
 
Primary Sponsor  
Name  AIIMS New delhi 
Address  ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS), New delhi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Niraj Kumar  AIIMS, New Delhi  Room no 709 7th floor Dept of Neuroanesthesiology Critical Care Neuroscience center 110029 New Delhi DELHI
South
DELHI 
9013770806

drnirajaiims@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS), Room no - 102, 1st floor O.T. Block, Ansari nagar New Delhi 110029  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 4||Measurement and Monitoring,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  All elective neurosurgical patients (age >18 years, ASA I II) requiring lateral positioning will be considered eligible.  
 
ExclusionCriteria 
Details  o Any recurrent cardiac arrhythmia; reduced ventricular systolic function - left (ejection fraction <40%),
o BMI more than 30
o Intra-operative use of vasopressors or inotropes before or during TVC
o Chronic lung disease
o Pre-operative use of beta blocking agents.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the reliability of changes in pulse pressure variation (PPV) and stroke volume variation (SVV) values induced by tidal volume challenge in predicting fluid responsiveness in patients undergoing neurosurgery in the lateral position under 6 ml/kg (PBW).  Starting point - At the point when lateral postion of the patint is achieved with hemodynamic stability.

End Point - At the point when Hemodynamic parameters are noted after the fluid challenge. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the reliability of pulse pressure variation (PPV) and stroke volume variation (SVV) at 6 ml/kg and 8 ml/kg.  Starting point - At the point when lateral postion of the patint is achieved with hemodynamic stability.

End Point - At the point when Hemodynamic parameters are noted after the fluid challenge. 
 
Target Sample Size   Total Sample Size="42"
Sample Size from India="42" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Perioperative management

·         All patients will receive standard intra-operative monitoring, including heart rate (HR), peripheral oxygen saturation (SpO2), continuous electrocardiography (ECG) and noninvasive blood pressure monitoring (NIBP).

·         After pre-oxygenation, general anaesthesia will be   induced   with   propofol, fentanyl and rocuronium (0.8 to 1 mg kg—1), and maintained with propofol (100 - 150 mcg kg—1 min—1) or sevoflurane (1to 2%) along with fentanyl (1 to 2 mcg kg—1 hr—1).

·         Anesthetic administration was targeted to maintain a bispectral index (BIS) of 40 to 60 throughout the surgical procedure.22

·         All patients will receive Sodium chloride(0.9%) solution at 4 ml/kg/hour as a maintenance fluid infusion during surgery and will be ventilated at baseline in volume-control mode with the following settings: VT of 6 ml/ kg PBW and positive end-expiratory pressure set 5 cmH2O to achieve and maintain a peripheral oxygen saturation of 96% and an end-tidal carbon dioxide (EtCo2) concentration between 30 and 35 mmHg.

·         The PBW (kg) will be calculated as follows: X 0.91[height (cm) - 152.4]; (X 50 for men and 45.5 for women).

·         After induction of general anesthesia, invasive blood pressure monitoring will be obtained by inserting a 20-G cannula into the radial artery.  A square-wave test will be used in all patients to exclude under or overdamping of the pressure signal.23

 

Hemodynamic monitoring

Radial artery catheter will be connected to the FlowTrac system (version 4.0; Edwards Lifesciences, Irvine, CA, USA). We will continuously monitor stroke volume (SV), stroke volume index (SVI), cardiac output (CO), cardiac index (CI) and SVV through FlowTrac /EV1000 system. 43,44 PPV will be continuously recorded on a Nihon -Kohden monitoring system (Nihon Kohden Corporation, Japan).

Study protocol

Measurements will be started during a period of hemodynamic stability (defined as changes in mean arterial pressure less than 10% over 5 min7,26) after positioning the patient in lateral. All readings will be taken before the skin incision.

     The study protocol will start with recording an initial set of measurements (Baseline).  TVC will be applied by increasing the TV up to 8 ml/ kg PBW and PPV and SVV changes were recorded (∆ PPV and ∆ SVV, respectively, calculated as percentage of variations between the values of PPV and SVV recorded at bassline -1 and 1 min after the VT increase).

Following this, the TV will be reduced back to 6 ml/ kg PBW and after 1 min, a set of measurements will be recorded (Baseline 2) and the fluid challenge (FC) of 250 ml of sodium chloride ( 0.9%) solution will be infused over 10 min and SV, SVI will be noted. Only the haemodynamic data, obtained from the first fluid challenge administered to each enrolled patient will be used for the analysis. Positive end-expiratory pressure will be kept constant during the study period. For the safety of the patient, the interruption of the protocol will be at discretion of the attending anesthetist.

 

Sample size calculation

·         The sample size of the study was calculated by means of the comparison of the areas under the ROC curves test (AUC). For this purpose, we predicted an AUC of at least   0.75, which is the threshold for considering a diagnostic test as accurate,29 and compared it with the null hypothesis (AUC 0.50; no discriminating power). Accordingly, a sample size of 38 patients was calculated (type I error of 5% and type II error of 20%). With the expectation of a 10% dropout rate, 42 patients will be enrolled in the study.

Statistical analysis

A receiver operating characteristic (ROC) curve approach will be used to evaluate the reliability of TVC test in predicting fluid responsiveness. ROC curves will be constructed for PPV and SVV values before fluid challenge administration; for the percentage change in PPV and SVV between 6- and 8-ml/ kg PBW ventilation after 1 min of TVC application.

A patient will be considered fluid responsive if the SVI increased at least 10% after fluid challenge administration.7,8 Cut-off values will be chosen with the highest Youden index and, finally, statistically significant ROC curves (P < 0.05) were compared using the De Long test.27  Normal distribution will be evaluated by means of the D’Agostino-Pearson test and, accordingly, data are expressed as median with interquartile [IQR] range or mean (SD).

Changes in continuous variables after TVC will be compared using a paired t test or Wilcoxon signed rank sum test, while an independent t test or Mann–Whitney U test was used for subgroup comparisons, as appropriate. For dichotomous or categorical variables, a Chi-square test for comparison of proportions will be applied. Statistical analyses will be conducted using STATA and or R software.

For all comparisons, we will consider significant P values less than 0.05.

 
Close